FrancophonIA/ELRC3.0 huggingface dataset:
English: No controlled clinical data are available on the use of Tekturna in patients with unilateral or bilateral renal artery stenosis, or stenosis to a solitary kidney.
Slovenian: Pri bolnikih z enostransko ali obojestransko stenozo ledvične arterije oziroma bolnikih s stenozo ledvične arterije v primeru solitarne ledvice o uporabi zdravila Tekturna ni na voljo podatkov iz kontroliranih kliničnih študij.
English: In a 6-month study of 599 patients with hypertension, type 2 diabetes mellitus, and nephropathy, all of whom were receiving losartan 100 mg and optimised antihypertensive background therapy, addition of Tekturna 300 mg achieved a 20% reduction versus placebo in urinary albumin:creatinine ratio (UACR), i.e. from 58 mg/mmol to 46 mg/mmol.
Slovenian: Dodajanje zdravila Tekturna v odmerku 300 mg je v primerjavi s placebom povzročilo 20-odstotno zmanjšanje razmerja med koncentracijo albumina in kreatinina v urinu (UACR - urinary albumin:creatinine ratio), to je od 58 mg/mmol na 46 mg/mmol.
English: - furosemide, a medicine belonging to the type known as diuretics, or “water” tablets, which is used to increase the amount of urine you produce.
Slovenian: in nadomestki kalija; - furosemid, to je zdravilo, ki sodi v skupino zdravil imenovano diuretiki ali tablete za odvajanje vode, zaradi katerih se poveča količina urina, ki nastaja v telesu; - ketokonazol, to je zdravilo za zdravljenje glivičnih okužb; - določene vrste zdravil proti bolečinam z imenom nesteroidna protivnetna zdravila.
English: BLISTER (CALENDAR)
Slovenian: PRETISNI OMOT PRETISNI OMOT (KOLEDARSKO PAKIRANJE)
English: Iron oxide, black (E 172) Iron oxide, red (E 172) Titanium dioxide (E 171)
Slovenian: 6.1 Seznam pomožnih snovi krospovidon magnezijev stearat mikrokristalna celuloza povidon brezvodni koloidni silicijev dioksid hipromeloza makrogol smukec črni železov oksid (E 172) rdeči železov oksid (E 172) titanov dioksid (E 171)
English: Tekturna 300 mg film-coated tablets Aliskiren
Slovenian: Tekturna 300 mg filmsko obložene tablete aliskiren
English: - if you are taking ciclosporin (a medicine used in transplantation to prevent organ rejection or for other conditions, e.g. rheumathoid arthritis or atopic dermatitis) or verapamil (a medicine used to lower blood pressure, to correct hearth rhythm or to treat angina pectoris) or quinidine (a medicine used to correct heart rhythm).
Slovenian: Ne jemljite zdravila Tekturna - če ste alergični (preobčutljivi) na aliskiren ali katerokoli sestavino zdravila Tekturna; če mislite, da bi lahko bili alergični, se posvetujte z zdravnikom; - če ste v času jemanja aliskirena že imeli kdaj angioedem (težave z dihanjem ali s požiranjem ali otekanje obraza, rok, stopal, oči, ustnic in/ali jezika); - v zadnjih 6 mesecih nosečnosti ali če dojite, glejte poglavje Nosečnost in dojenje; - če jemljete ciklosporin (zdravilo, ki se ga uporablja pri presaditvah za preprečevanje zavrnitve organa ali pri drugih boleznih, na primer pri revmatoidnem artritisu ali atopijskem dermatitisu), če jemljete verapamil (zdravilo za zniževanje krvnega tlaka, uravnavanje srčnega ritma ali za zdravljenje angine pektoris) ali če jemljete kinidin (zdravilo za uravnavanje srčnega ritma).
English: NAME OF THE MEDICINAL PRODUCT Tekturna 150 mg film-coated tablets
Slovenian: IME ZDRAVILA Tekturna 150 mg filmsko obložene tablete
English: NAME OF THE MEDICINAL PRODUCT Tekturna 300 mg film-coated tablets
Slovenian: IME ZDRAVILA Tekturna 300 mg filmsko obložene tablete
English: 14 film-coated tablets
Slovenian: filmsko obložena tableta
English: Novartis Pharma Servic Tel: +386 1 300 75 77
Slovenian: Novartis Pharma Services Inc. Tel: +386 1 300 75 77
English: Therefore as with any agent acting on the RAS system, routine monitoring of electrolytes and renal function is indicated in patients with diabetes mellitus, kidney disease, or heart failure.
Slovenian: Zato je pri bolnikih s sladkorno boleznijo, z ledvično boleznijo ali s popuščanjem srca indicirano rutinsko spremljanje vrednosti elektrolitov in delovanja ledvic, tako kot pri vsaki učinkovini, ki deluje na sistem renin-angiotenzin.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg aliskiren (as hemifumarate).
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka filmsko obložena tableta vsebuje 300 mg aliskirena (v obliki hemifumarata).
English: Multipack comprising 2 packs, each containing 49 tablets.
Slovenian: 98 filmsko obloženih tablet skupno pakiranje z 2 škatlama, vsaka škatla vsebuje 49 tablet.
English: Multipack comprising 20 packs, each containing 14 tablets.
Slovenian: 280 filmsko obloženih tablet skupno pakiranje z 20 škatlami, vsaka škatla vsebuje 14 tablet.
English: No adjustment of the initial dose is required for patients with mild to severe hepatic impairment (see section 5.2).
Slovenian: Bolnikom z blago do hudo okvaro jeter ni potrebno prilagajati začetnega odmerka (glejte poglavje
English: Potassium and potassium-sparing diuretics
Slovenian: Kalij in diuretiki, ki varčujejo s kalijem
English: The change in plasma levels of aliskiren in the presence of ketoconazole is expected to be within the range that would be achieved if the dose of aliskiren were doubled; aliskiren doses of up to 600 mg, or twice the highest recommended therapeutic dose, have been found to be well tolerated in controlled clinical trials.
Slovenian: V kontroliranih kliničnih preskušanjih so ugotovili, da so preiskovanci dobro prenašali odmerke aliskirena tudi do 600 mg oziroma odmerke, ki so bili dvakrat višji od najvišjega priporočenega terapevtskega odmerka.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 150 mg aliskiren (as hemifumarate).
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka filmsko obložena tableta vsebuje 150 mg aliskirena (v obliki hemifumarata).
English: What Tekturna looks like and contents of the pack Tekturna 150 mg film coated tablets are light-pink, biconvex round tablets, imprinted “IL” on one side and “NVR” on the other side.
Slovenian: Tekturna 150 mg filmsko obložene tablete so bikonveksne okrogle tablete svetlo roza barve, z oznako ‘IL' na eni strani in ‘NVR' na drugi.
English: Multipack comprising 3 packs, each containing 28 tablets.
Slovenian: 84 filmsko obloženih tablet skupno pakiranje s 3 škatlami, vsaka škatla vsebuje 28 tablet.
English: Film-coated tablet Light-red, biconvex, ovaloid tablet, imprinted “IU” on one side and “NVR” on the other side.
Slovenian: Bikonveksna ovalna tableta svetlo rdeče barve, z vtisnjeno oznako ‘IU' na eni strani in ‘NVR' na drugi.
English: Multipack comprising 3 packs, each containing 30 tablets.
Slovenian: 90 filmsko obloženih tablet skupno pakiranje s 3 škatlami, vsaka škatla vsebuje 30 tablet.
English: What Tekturna looks like and contents of the pack Tekturna 300 mg film coated tablets are light-red, biconvex, ovaloid tablets, imprinted “IU” on one side and “NVR” on the other side.
Slovenian: Tekturna 300 mg filmsko obložene tablete so bikonveksne ovalne tablete svetlo rdeče barve, z oznako ‘IU' na eni strani in ‘NVR' na drugi.
English: Film-coated tablet Light-pink, biconvex, round tablet, imprinted “IL” on one side and “NVR” on the other side.
Slovenian: Bikonveksna okrogla tableta svetlo roza barve, z vtisnjeno oznako ‘IL' na eni strani in ‘NVR' na drugi.
English: Take special care with Tekturna - if you are taking a diuretic (a type of medicine also known as “water” tablets which increases the amount of urine you produce).
Slovenian: Bodite posebno pozorni pri uporabi zdravila Tekturna - kadar jemljete diuretike (vrsta zdravil za odvajanje vode, ki povečuje količino urina, ki nastaja v telesu); - če imate moteno delovanje ledvic; - če pride do angioedema (težav z dihanjem ali s požiranjem ali do otekanja obraza, rok, stopal,
English: As for other agents acting on the renin-angiotensin system, caution should be exercised when aliskiren is given in the presence of conditions pre-disposing to kidney dysfunction such as hypovolaemia (eg.
Slovenian: Kot pri uporabi drugih zdravil, ki delujejo na sistem renin-angiotenzin, je potreba previdnost pri uporabi aliskirena pri bolnikih z drugimi boleznimi, zaradi katerih so bolj nagnjeni k slabšemu delovanju ledvic, kot so hipovolemija (na primer zaradi izgube krvi, hude ali dolgotrajne diareje, dolgotrajnega bruhanja in podobno), bolezni srca, jeter ali ledvic.
English: What Tekturna contains - The active substance is aliskiren (as hemifumarate) 150 mg. - The other ingredients are crospovidone, hypromellose, magnesium stearate, macrogol,
Slovenian: Kaj vsebuje zdravilo Tekturna - Zdravilna učinkovina je aliskiren (v obliki hemifumarata) 150 mg. - Pomožne snovi so: krospovidon, hipromeloza, magnezijev stearat, makrogol, mikrokristalna celuloza, povidon, brezvodni koloidni silicijev dioksid, smukec, titanov dioksid (E 171), črni železov oksid (E 172), rdeči železov oksid (E 172).
English: microcrystalline cellulose, povidone, colloidal anhydrous silica, talc, titanium dioxide (E 171),
Slovenian: Kaj vsebuje zdravilo Tekturna - Zdravilna učinkovina je aliskiren (v obliki hemifumarata) 300 mg. - Pomožne snovi so: krospovidon, hipromeloza, magnezijev stearat, makrogol, mikrokristalna celuloza, povidon, brezvodni koloidni silicijev dioksid, smukec, titanov dioksid (E 171), črni železov oksid (E 172), rdeči železov oksid (E 172).
English: Tekturna induced an additive blood-pressure-lowering effect when added to hydrochlorothiazide and to ramipril.
Slovenian: Če so zdravilo Tekturna dodali hidroklorotiazidu in ramiprilu, je povzročilo aditiven učinek zniževanja krvnega tlaka.
English: In hypertensive patients, once-daily administration of Tekturna at doses of 150 mg and 300 mg provided dose-dependent reductions in both systolic and diastolic blood pressure that were maintained over the entire 24-hour dose interval (maintaining benefit in the early morning) with a mean peak to trough ratio for diastolic response of up to 98% for the 300 mg dose.
Slovenian: Znižanje krvnega tlaka je bilo odvisno od velikosti odmerka in se je ohranilo skozi celoten 24-urni interval odmerjanja (ohranjena koristnost učinka v zgodnjih jutranjih urah).
English: You may feel dizzy and this can affect your ability to concentrate.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Morda boste nekoliko omotični in se zato ne boste mogli zbrati.
English: 49 film-coated tablets
Slovenian: 49 filmsko obloženih tablet del skupnega pakiranja z 2 škatlama po 49 tablet
English: Each film-coated tablet contains 300 mg aliskiren (as hemifumarate).
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Vsaka filmsko obložena tableta vsebuje 300 mg aliskirena (v obliki hemifumarata).
English: Always take Tekturna exactly as your doctor has told you.
Slovenian: Pri jemanju zdravila Tekturna natančno upoštevajte zdravnikova navodila.
English: Each film-coated tablet contains 150 mg aliskiren (as hemifumarate).
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Vsaka filmsko obložena tableta vsebuje 150 mg aliskirena (v obliki hemifumarata).
English: Do not breast-feed if you are taking Tekturna.
Slovenian: Če jemljete zdravilo Tekturna, ne smete dojiti.
English: It is a ‘generic medicine'.
Slovenian: Je „generično zdravilo“.
English: Both are antihypertensive medicines that have been available separately in the European Union (EU) since the mid1990s.
Slovenian: Obe učinkovini sta zdravili proti zvišanemu krvnemu tlaku, ki sta bili v Evropski uniji (EU) od sredine 90-ih let prejšnjega stoletja na voljo kot ločeni zdravili.
English: One tablet is taken daily by mouth with water.
Slovenian: Odmerek je ena tableta dnevno peroralno z vodo.
English: It blocks special channels on the surface of cells through which calcium normally enters the cells.
Slovenian: Zdravilo zavira posebne kanalčke na površini celic, skozi katere v celico običajno vstopa kalcij.
English: Amlodipine/Valsartan Mylan is available as tablets (5 mg amlodipine and 80 mg valsartan; 5 mg amlodipine and 160 mg valsartan; 10 mg amlodipine and 160 mg valsartan).
Slovenian: Zdravilo Amlodipin/Valsartan Mylan je na voljo v obliki tablet (5 mg amlodipina in 80 mg valsartana; 5 mg amlodipina in 160 mg valsartana; 10 mg amlodipina in 160 mg valsartana).
English: Valsartan is an ‘angiotensin II receptor antagonist', which means that it blocks the action of a hormone in the body called angiotensin II.
Slovenian: Valsartan je „antagonist receptorja za angiotenzin II“, kar pomeni, da zavira delovanje telesnega hormona, imenovanega angiotenzin II.
English: It is recommended that the patient takes amlodipine and valsartan as separate tablets or capsules before switching to the combination tablet.
Slovenian: Priporočljivo je, da bolnik že jemlje amlodipin in valsartan kot ločene tablete ali kapsule, preden preide na kombinirane tablete.
English: The full EPAR for Amlodipine/Valsartan Mylan can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Amlodipin/Valsartan Mylan je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The strength of the tablet to be used depends on the doses of amlodipine or valsartan that the patient was taking before.
Slovenian: Jakost tablete, ki jo je treba vzeti, je odvisna od odmerkov amlodipina ali valsartana, ki jih je bolnik jemal prej.
English: This is a summary of the European public assessment report (EPAR) for Amlodipine/Valsartan Mylan.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Amlodipin/Valsartan Mylan.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Amlodipine/Valsartan Mylan has been shown to have comparable quality and to be bioequivalent/be comparable to Exforge.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Amlodipin/Valsartan Mylan primerljivo raven kakovosti kot zdravilo Exforge ter da mu je biološko enakovredno/je z njim primerljivo.
English: Amlodipine/Valsartan Mylan is a medicine used in patients who have essential hypertension (high blood pressure) that is not adequately controlled on either amlodipine or valsartan taken alone.
Slovenian: Zdravilo Amlodipin/Valsartan Mylan se uporablja pri bolnikih, ki imajo esencialno hipertenzijo (visok krvni tlak), ki je ni mogoče ustrezno uravnati samo z amlodipinom ali valsartanom.
English: Because Amlodipine/Valsartan Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Amlodipin/Valsartan Mylan generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: The Committee recommended that Amlodipine/Valsartan Mylan be approved for use in the EU.
Slovenian: Priporočil je, da se zdravilo Amlodipin/Valsartan Mylan odobri za uporabo v EU.
English: They work in similar ways to reduce blood pressure by allowing the blood vessels to relax.
Slovenian: Obe podobno znižujeta krvni tlak, in sicer tako, da spodbujata sprostitev krvnih žil.
English: Amlodipine/Valsartan Mylan amlodipine / valsartan
Slovenian: Amlodipin/Valsartan Mylan amlodipin/valsartan
English: For more information about treatment with Amlodipine/Valsartan Mylan, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Amlodipin/Valsartan Mylan preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: What measures are being taken to ensure the safe and effective use of Amlodipine/Valsartan Mylan?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Amlodipin/Valsartan Mylan?
English: For practical information about using Amlodipine/Valsartan Mylan, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Amlodipin/Valsartan Mylan naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: When calcium enters the cells in the muscles of blood vessel walls, this causes contraction.
Slovenian: Ko kalcij vstopi v celice mišic v stenah žil, se te začnejo krčiti.
English: Because Amlodipine/Valsartan Mylan is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Exforge.
Slovenian: Ker je zdravilo Amlodipin/Valsartan Mylan generično zdravilo, so bile študije pri ljudeh omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Exforge.
English: A risk management plan has been developed to ensure that Amlodipine/Valsartan Mylan is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Amlodipin/Valsartan Mylan je bil pripravljen načrt obvladovanja tveganj.
English: Therefore, the CHMP's view was that, as for Exforge, the benefit outweighs the identified risk.
Slovenian: Zato je menil, da njegove koristi enako kot pri zdravilu Exforge odtehtajo znana tveganja.
English: By reducing the flow of calcium into the cells, amlodipine prevents the cells from contracting and this helps the blood vessels to relax.
Slovenian: Amlodipin z zmanjšanjem pretoka kalcija v celice prepreči njihovo krčenje in pomaga pri sproščanju sten žil.
English: Other information about Amlodipine/Valsartan Mylan
Slovenian: Druge informacije o zdravilu Amlodipin/Valsartan Mylan
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Amlodipine/Valsartan Mylan, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: What are the benefits and risks of Amlodipine/Valsartan Mylan?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Amlodipin/Valsartan Mylan?
English: This means that Amlodipine/Valsartan Mylan is similar to a ‘reference medicine' already authorised in the European Union (EU) called Exforge.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Exforge.
English: Amlodipine/Valsartan Mylan contains two active substances, amlodipine and valsartan.
Slovenian: Zdravilo Amlodipin/Valsartan Mylan vsebuje dve učinkovini, amlodipin in valsartan.
English: What is Amlodipine/Valsartan Mylan and what is it used for?
Slovenian: Kaj je zdravilo Amlodipin/Valsartan Mylan in za kaj se uporablja?
English: Why is Amlodipine/Valsartan Mylan approved?
Slovenian: Zakaj je bilo zdravilo Amlodipin/Valsartan Mylan odobreno?
English: How is Amlodipine/Valsartan Mylan used?
Slovenian: Kako se zdravilo Amlodipin/Valsartan Mylan uporablja?
English: How has Amlodipine/Valsartan Mylan been studied?
Slovenian: Kako je bilo zdravilo Amlodipin/Valsartan Mylan raziskano?
English: How does Amlodipine/Valsartan Mylan work?
Slovenian: Kako zdravilo Amlodipin/Valsartan Mylan deluje?
English: This overview was last updated in February 2019.
Slovenian: Povzetek je bil nazadnje posodobljen februarja 2019.
English: Horses were examined at days 14, 35 and 63.
Slovenian: Konje so pregledali na 14., 35. in 63. dan.
English: Substantial improvement occurs in the next 48 hours with complete resolution in the following two weeks.
Slovenian: V naslednjih 48 urah se je pokazalo pomembno izboljšanje, v naslednjih dveh tednih pa popolna remisija.
English: Further information on HorStem can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/horstem.
Slovenian: Nadaljnje informacije o zdravilu HorStem so na voljo na spletni strani agencije: ema.europa.eu/medicines/veterinary/EPAR/horstem.
English: Stem cells can develop into other types of cells.
Slovenian: Matične celice se lahko razvijejo v druge vrste celic.
English: Other information about HorStem
Slovenian: Druge informacije o zdravilu HorStem
English: The European Medicines Agency decided that HorStem's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila HorStem večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: In case of severe inflammation, treatment with an anti-inflammatory medicine (NSAID) might be necessary.
Slovenian: V primeru hudega vnetja je morda potrebno zdravljenje z nesteroidnimi protivnetnimi zdravili (NSAID).
English: Hands should be washed after handling the medicine.
Slovenian: Po rokovanju z zdravilom si je treba umiti roke.
English: Mesenchymal stem cells can have effects on the immune system as well as anti-inflammatory effects and can possess tissue regenerative properties.
Slovenian: Mezenhimske matične celice lahko vplivajo na imunski sistem in imajo protivnetne učinke; poleg tega imajo lahko regenerativne lastnosti na tkiva.
English: HorStem received a marketing authorisation valid throughout the EU on 19 June 2019.
Slovenian: Zdravilo HorStem je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 19/06/2019.
English: Why is HorStem authorised in the EU?
Slovenian: Zakaj je zdravilo HorStem odobreno v EU?
English: What benefits of HorStem have been shown in studies?
Slovenian: Kakšne koristi je zdravilo HorStem izkazalo v študijah?
English: These are stem cells taken from the umbilical cord of donor horses when a foal is born and grown in a laboratory to increase their numbers.
Slovenian: To so matične celice, ki so bile odvzete iz popkovnice konjev darovalcev in gojene v laboratoriju, da se poveča njihovo število.
English: Twelve HorStem treated horses were successfully treated (success rate 75%) at day 63 compared to only 4 of the control group (success rate 25%).
Slovenian: Dvanajst konjev, zdravljenih z zdravilom HorStem, je bilo uspešno pozdravljenih (75-odstotna stopnja uspešnosti) na 63. dan v primerjavi s samo štirimi konji v kontrolni skupini (25-odstotna stopnja uspešnosti).
English: What are the risks associated with HorStem?
Slovenian: Kakšna tveganja so povezana z zdravilom HorStem?
English: An overview of HorStem and why it is authorised in the EU
Slovenian: Pregled zdravila HorStem in zakaj je odobreno v EU
English: What is HorStem and what is it used for?
Slovenian: Kaj je zdravilo HorStem in za kaj se uporablja?
English: These properties are expected to play a role in the effect of HorStem.
Slovenian: Te lastnosti naj bi imele vlogo pri učinkovanju zdravila HorStem.
English: For more information about using HorStem, see the package leaflet or contact your veterinarian or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila HorStem glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
English: Treatment success was a reduction in lameness to a grade of 1 or less, using an accepted scale for equine lameness measurement (scale from 0 to 5, where 0 is nonlame, and 5 is severely lame).
Slovenian: Uspeh zdravljenja je bil zmanjšanje šepavosti do stopnje 1 ali manj po odobreni lestvici za merjenje šepavosti konjev (lestvica od 0 do 5, pri čemer je stopnja 0 pomenila brez šepavosti, stopnja 5 pa huda šepavost).
English: The withdrawal period for meat from horses treated with HorStem is ‘zero' days, which means that there is no mandatory waiting time.
Slovenian: Karenca za meso konjev, zdravljenih z zdravilom HorStem, je nič dni, kar pomeni, da ni obvezne čakalne dobe.